Exelixis (EXEL) Tax Rate Growth (5y) (2017 - 2026)
Exelixis (EXEL) Tax Rate Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - |
| 10 | Exelixis | 14.49 Bn | 13.71 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -15,808.00 |
| Jan 2, 2026 | -1,969.00 |
| Oct 3, 2025 | 758.00 |
| Jul 4, 2025 | 258.00 |
| Apr 4, 2025 | 337.00 |
| Sep 27, 2024 | 322.00 |
| Jun 28, 2024 | 201.00 |
| Mar 29, 2024 | 783.00 |
| Dec 29, 2023 | 22,643.00 |
| Sep 29, 2023 | 8,031.00 |
| Jun 30, 2023 | 1,811.00 |
| Mar 31, 2023 | 1,496.00 |
| Dec 30, 2022 | 289.00 |
| Sep 30, 2022 | 1,667.00 |
| Jul 1, 2022 | 1,697.00 |
| Apr 1, 2022 | 1,875.00 |
| Dec 28, 2018 | -20,956.00 |
| Dec 29, 2017 | 124.00 |
| Sep 29, 2017 | 382.00 |
| Jun 30, 2017 | 322.00 |